Industry: Health care Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French company is committed to designing and producing intraocular implants for refractive surgery and cataract surgery. As a manufacturer of French ophthalmology industry, the company controls the whole business process from raw material development to packaging, and its medical device products have passed CE certification. In addition, the company won the 2013 research and innovation award for the invention of its new hydrophobic materials. It combines the characteristics of hydrophilic (small incision, but there is a risk of opacity) and hydrophobic (harder) acrylic implants, while limiting the incision.
Product advantages:
1. Product safety
The company cooperates with ISO-certified suppliers in ophthalmology industry, and has a high-performance clean room for pre-cleaning, polishing, optical control and final inspection in the production process, which has passed ISO 9001 and NF EN ISO 13485 certification.
2. Independent production
The company has incorporated all stages of lens manufacturing into its production process in order to fully control its products. The company is responsible for design, raw material polymerization, low-temperature processing, inspection of each lens in a clean room and logistics services, which makes its production completely independent and realizes real value-added.
Step 3 innovate
By integrating Ph.D. in chemistry, optical engineers and biomaterials researchers into the R&D team, the company is preparing for future implantable devices.
Cooperation mode:
Looking for partners who need refractive surgery and cataract surgery.